Showing results (21-30 of 1,457) with videos related to
Sort By:
Pageof 146
Pharmacogenetics and Genomics|August 2, 2022
Attitudes on pharmacogenomic results as secondary findings among medical geneticistsMeghan N Bartos, Stuart A Scott, Ethylin Wang Jabs, et al.BMC Medical Genomics|March 20, 2019
Familial inheritance of the 3q29 microdeletion syndrome: case report and reviewWahab A Khan, Ninette Cohen, Stuart A Scott, et al.Bioresource Technology|May 24, 2014
Life cycle assessment on microalgal biodiesel production using a hybrid cultivation systemVictoria O Adesanya, Erasmo Cadena, Stuart A Scott, et al.Patient Education and Counseling|May 18, 2026
Delivering pharmacogenomic results via electronic health record patient portals: Impacts of health literacy and genetics knowledgeSavannah L Kile, Aniwaa Owusu-Obeng, Stuart A Scott, et al.Journal of Hematology & Oncology|May 17, 2012
Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutationNaoto Takahashi, Masatomo Miura, Stuart A Scott, et al.Clinical and Translational Science|June 4, 2014
CYP2C9 allelic variants and frequencies in a pediatric sickle cell disease cohort: implications for NSAIDs pharmacotherapyCheedy Jaja, Niren Patel, Stuart A Scott, et al.Pharmacogenomics|May 28, 2010
Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groupsStuart A Scott, Rame Khasawneh, Inga Peter, et al.Human Molecular Genetics|June 24, 2010
Large inverted repeats within Xp11.2 are present at the breakpoints of isodicentric X chromosomes in Turner syndromeStuart A Scott, Ninette Cohen, Tracy Brandt, et al.Bioresource Technology|March 1, 2014
Kinetic modelling of growth and storage molecule production in microalgae under mixotrophic and autotrophic conditionsVictoria O Adesanya, Matthew P Davey, Stuart A Scott, et al.Pharmacogenomics|February 5, 2008
CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish populationStuart A Scott, Lisa Edelmann, Ruth Kornreich, et al.Pageof 146